• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋来源的 14 元环雷锁辛内酯衍生物的抗活性研究。

Study on the Anti- Activity of a Series of Marine-Derived 14-Membered Resorcylic Acid Lactone Derivatives.

机构信息

Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, College of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China.

出版信息

Mar Drugs. 2024 Mar 16;22(3):135. doi: 10.3390/md22030135.

DOI:10.3390/md22030135
PMID:38535476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10972006/
Abstract

With the emergence of drug-resistant strains, the treatment of tuberculosis (TB) is becoming more difficult and there is an urgent need to find new anti-TB drugs. , as a model organism of , can be used for the rapid and efficient screening of bioactive compounds. The 14-membered resorcylic acid lactones (RALs) have a wide range of bioactivities such as antibacterial, antifouling and antimalarial activity. In order to further study their bioactivities, we initially constructed a 14-membered RALs library, which contains 16 new derivatives. The anti- activity was evaluated in vitro. Derivatives , , and exhibited promising activity with MIC values of 80, 90, 80 and 80 μM, respectively. The preliminary structure-activity relationships showed that the presence of a chlorine atom at C-5 was a key factor to improve activity. Further studies showed that markedly inhibited the survival of and significantly reduced the dosage of positive drugs isoniazid and rifampicin when combined with them. These results suggest that is a bioactive compound capable of enhancing the potency of existing positive drugs, and its effective properties make it a very useful leads for future drug development in combating TB resistance.

摘要

随着耐药菌株的出现,结核病(TB)的治疗变得更加困难,迫切需要寻找新的抗结核药物。 作为 的模式生物,可以用于快速高效地筛选生物活性化合物。 具有广泛的生物活性,如抗菌、防污和抗疟活性。 为了进一步研究它们的生物活性,我们最初构建了一个 14 元环的 resorcylic 酸内酯(RALs)文库,其中包含 16 个新衍生物。 在体外评估了它们的抗 活性。 衍生物 、 、 和 表现出有希望的活性,MIC 值分别为 80、90、80 和 80 μM。 初步的结构-活性关系表明,C-5 位上存在氯原子是提高活性的关键因素。 进一步的研究表明 显著抑制了 和 的存活,并显著降低了与阳性药物异烟肼和利福平联合使用时的剂量。 这些结果表明 是一种能够增强现有阳性药物效力的生物活性化合物,其有效特性使其成为未来抗结核耐药性药物开发非常有用的先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fda80ceef936/marinedrugs-22-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fe2325ed97b7/marinedrugs-22-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/7fd82c7fd4b1/marinedrugs-22-00135-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/c2fec05a28de/marinedrugs-22-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fbf408bd0711/marinedrugs-22-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fda80ceef936/marinedrugs-22-00135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fe2325ed97b7/marinedrugs-22-00135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/7fd82c7fd4b1/marinedrugs-22-00135-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/c2fec05a28de/marinedrugs-22-00135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fbf408bd0711/marinedrugs-22-00135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c4a/10972006/fda80ceef936/marinedrugs-22-00135-g004.jpg

相似文献

1
Study on the Anti- Activity of a Series of Marine-Derived 14-Membered Resorcylic Acid Lactone Derivatives.海洋来源的 14 元环雷锁辛内酯衍生物的抗活性研究。
Mar Drugs. 2024 Mar 16;22(3):135. doi: 10.3390/md22030135.
2
Heterologous Expression of and in Mycobacterium marinum Enables the Rapid Identification of New Prodrugs Active against Mycobacterium tuberculosis.在海分枝杆菌中异源表达和 ,可快速鉴定新型抗结核分枝杆菌前药。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01445-20.
3
Synthesis of Long-Chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria.长链β-内酰胺的合成及其对致病性分枝杆菌的抗菌活性。
ChemMedChem. 2019 Feb 5;14(3):349-358. doi: 10.1002/cmdc.201800720. Epub 2019 Jan 17.
4
Enhance the Antimycobacterial Activity of Streptomycin with Ebselen as an Antibiotic Adjuvant Through Disrupting Redox Homeostasis.通过破坏氧化还原稳态,用埃斯硒作为抗生素佐剂增强链霉素的抗分枝杆菌活性。
Drug Des Devel Ther. 2024 Aug 27;18:3811-3824. doi: 10.2147/DDDT.S475535. eCollection 2024.
5
Synthesis and biological evaluation of 2-(Tetrazol-5-yl)sulfonylacetamides as inhibitors of Mycobacterium tuberculosis and Mycobacterium marinum.2-(四唑-5-基)磺酰基乙酰胺类化合物的合成及抗结核分枝杆菌和海分枝杆菌活性评价
Bioorg Med Chem Lett. 2023 Aug 15;92:129391. doi: 10.1016/j.bmcl.2023.129391. Epub 2023 Jun 25.
6
Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model.在天然感染的斑马鱼幼虫模型中筛选抗分枝杆菌化合物。
J Antimicrob Chemother. 2017 Feb;72(2):421-427. doi: 10.1093/jac/dkw421. Epub 2016 Oct 24.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.鉴定一种新型异柠檬酸裂解酶抑制剂作为针对活性和非复制性结核分枝杆菌的强效抗结核药物。
Tuberculosis (Edinb). 2016 Mar;97:38-46. doi: 10.1016/j.tube.2015.12.003. Epub 2016 Jan 6.
9
Potential of Mycobacterium vanbaalenii as a model organism to study drug transporters of Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans: homology analysis of M. tuberculosis drug transporters among mycobacterial species.分枝杆菌 vanbaalenii 作为研究结核分枝杆菌、海分枝杆菌和溃疡分枝杆菌药物转运蛋白的模式生物的潜力:分枝杆菌属中结核分枝杆菌药物转运蛋白的同源性分析。
Infect Genet Evol. 2012 Jun;12(4):853-6. doi: 10.1016/j.meegid.2011.10.028. Epub 2011 Nov 23.
10
Structure modification, antialgal, antiplasmodial, and toxic evaluations of a series of new marine-derived 14-membered resorcylic acid lactone derivatives.一系列新的海洋来源的14元间苯二酚内酯衍生物的结构修饰、抗藻、抗疟及毒性评价
Mar Life Sci Technol. 2021 Jun 28;4(1):88-97. doi: 10.1007/s42995-021-00103-0. eCollection 2022 Feb.

引用本文的文献

1
Semisynthesis, Structure Elucidation and Anti- Activity of a Series of Marine-Derived 14-Membered Resorcylic Acid Lactones with Interesting Ketal Groups.半合成、结构解析及一系列含有趣缩醛基的海洋衍生 14 元环 resorcylic acid lactones 的抗活性研究。
Mar Drugs. 2024 Sep 25;22(10):431. doi: 10.3390/md22100431.

本文引用的文献

1
A half-century of research on tuberculosis: Successes and challenges.半个世纪的结核病研究:成就与挑战。
J Exp Med. 2023 Sep 4;220(9). doi: 10.1084/jem.20230859. Epub 2023 Aug 8.
2
Structure modification, antialgal, antiplasmodial, and toxic evaluations of a series of new marine-derived 14-membered resorcylic acid lactone derivatives.一系列新的海洋来源的14元间苯二酚内酯衍生物的结构修饰、抗藻、抗疟及毒性评价
Mar Life Sci Technol. 2021 Jun 28;4(1):88-97. doi: 10.1007/s42995-021-00103-0. eCollection 2022 Feb.
3
Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant .
BRD4-HDAC 双重抑制剂的发现具有改善的真菌选择性和对氟康唑耐药的. 的强大协同抗真菌活性
J Med Chem. 2023 Apr 27;66(8):5950-5964. doi: 10.1021/acs.jmedchem.3c00165. Epub 2023 Apr 10.
4
Proteo-genetic analysis reveals clear hierarchy of ESX-1 secretion in .蛋白-遗传分析揭示.中 ESX-1 分泌的明显层次结构。
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2123100119. doi: 10.1073/pnas.2123100119. Epub 2022 Jun 7.
5
Marine natural products.海洋天然产物。
Nat Prod Rep. 2022 Jun 22;39(6):1122-1171. doi: 10.1039/d1np00076d.
6
Trends of antimalarial marine natural products: progresses, challenges and opportunities.抗疟海洋天然产物的研究趋势:进展、挑战与机遇
Nat Prod Rep. 2022 May 26;39(5):969-990. doi: 10.1039/d1np00075f.
7
An anti-tuberculosis compound screen using a zebrafish infection model identifies an aspartyl-tRNA synthetase inhibitor.利用斑马鱼感染模型进行抗结核化合物筛选,鉴定出一种天冬氨酰-tRNA 合成酶抑制剂。
Dis Model Mech. 2021 Dec 1;14(12). doi: 10.1242/dmm.049145. Epub 2021 Dec 23.
8
Anti-mycobacterial natural products and mechanisms of action.抗分枝杆菌天然产物及其作用机制。
Nat Prod Rep. 2022 Jan 26;39(1):77-89. doi: 10.1039/d1np00011j.
9
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.天然产物:1981 年 1 月至 2019 年 9 月近四十年来的新药来源
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
10
Pretomanid: First Approval.苯并异噻唑酮(pretomanid):首次批准。
Drugs. 2019 Nov;79(16):1797-1803. doi: 10.1007/s40265-019-01207-9.